FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 67 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $180,000 | -37.3% | 50,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $287,000 | -48.3% | 50,000 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $555,000 | +19.9% | 50,000 | 0.0% | 0.00% | +100.0% |
| Q3 2016 | $463,000 | -4.9% | 50,000 | -16.7% | 0.00% | -50.0% |
| Q4 2015 | $487,000 | +10.7% | 60,000 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $440,000 | -28.5% | 60,000 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $615,000 | +10.8% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $555,000 | +58.1% | 60,000 | +20.0% | 0.00% | +100.0% |
| Q4 2014 | $351,000 | +28.6% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $273,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,293,177 | $4,643,000 | 4.08% |
| GREAT POINT PARTNERS LLC | 4,047,561 | $14,531,000 | 1.84% |
| Sio Capital Management, LLC | 1,151,510 | $4,134,000 | 1.51% |
| DAFNA Capital Management LLC | 808,000 | $2,901,000 | 1.44% |
| Diag Capital Management, LP | 146,432 | $960,000 | 1.10% |
| Perceptive Advisors | 4,661,824 | $15,850,000 | 0.60% |
| Eversept Partners, LP | 294,660 | $1,057,829 | 0.57% |
| Sofinnova Investments, Inc. | 832,293 | $2,987,000 | 0.37% |
| KNOTT DAVID M | 206,200 | $740,000 | 0.35% |
| Orbimed Advisors | 5,195,330 | $18,651,000 | 0.34% |